Delivery Order SPE2DB20D1109-SPE2DB24FP74X

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has a ceiling value of $6,371.46 and a period of performance through July 15, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a medication used to treat diabetes. The contract has a ceiling value of $1,022.80 and runs through February 11, 2025. The contract is a firm fixed-price, delivery order contract with no set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a prescription medication. The contract has a ceiling value of $1,227.36 and runs through March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used for the treatment of diabetes. The contract has a ceiling value of $2,848.60 and a period of performance through February 20, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus SoloStar, a 100 unit/mL, 3 mL insulin product, with a ceiling value of $2,415.58 and a period of performance through January 14, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Medical Supply Chain component of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,933.53, is for the supply of Lantus SoloStar 100 Unit/mL 3mL, a specialty medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used for the treatment of diabetes. The contract has a ceiling value of $1,190.92 and a completion date of February 27, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication used for the treatment of diabetes. The contract has a ceiling value of $1,537.64 and a period of performance through July 15, 2024. This order was placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 Unit/mL 3mL medical products. The contract has a ceiling value of $8,184.41 and runs through February 19, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm-fixed-price contract is for the supply of Lantus SoloStar 100 unit/ml 3 ml, a medication used to treat diabetes. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP74X
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a specialty medication used for the treatment of diabetes. The delivery order has a ceiling value of $4,616.68 and runs through August 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and covering a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The DLA is the primary contracting agency, responsible for providing medical commodities, including specialty medications, generic drugs, and other essential medical products, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 11:05 AM